Why the study?
Does early discharge and ambulatory oral anticoagulation improve survival and quality of life in selected patients with low-risk pulmonary embolism?
Does early discharge and ambulatory oral anticoagulation improve survival and quality of life in selected patients with low-risk pulmonary embolism?
Early discharge and ambulatory oral anticoagulation are supported for low-risk pulmonary embolism, though quality of life optimization may require targeted approaches.
Answers are grounded in this paper and cite their sources.
May support early discharge in low-risk PE; leaves open targeted QoL strategies for subgroups pending RCTs.
Our results further support early discharge and ambulatory oral anticoagulation for selected patients with low-risk pulmonary embolism. Targeted strategies may be necessary to further improve quality of life in specific patient subgroups.
No takes yet. Share an insight, caveat, or question.
Barco et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: